TCT 618: Impact of Anterior, Posterior and Bi-leaflet Disease on Clinical Outcomes: Results From the EXPANDed Studies
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Abbott Vascular; W.L. Gore & Associates
- Grant Support/Research Contract - Abbott Vascular; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; HiLife
- PI of CHAMPION AF and PINNACLE FLX trials - Boston Scientific Corporation
- PI of Repair MR trial and EXPAND registry - Abbott Vascular
- member of Scientific Advisory Board - Laminar
- Member of Scientific Advisory Board - InterShunt Technologies